Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-027010
Filing Date
2021-07-01
Accepted
2021-07-01 18:52:42
Documents
1
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3079
  Complete submission text file 0000899243-21-027010.txt   4622
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Lee John H. (Reporting) CIK: 0001834215 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 211067502